ScreenerHero

IBO Impact BioMedical Inc.

AMEX · US · Healthcare · Biotechnology · impactbiomedinc.com
4.110USD-8.26%Mkt Cap: 35.11M $P/E: 0.37

Impact BioMedical Inc. discovers, develops, and commercializes products and technologies to address unmet needs in human healthcare and wellness for specialty biopharmaceuticals, antivirals, antimicrobials, consumer heal…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.47BUSDP/E 29.3
MRNA
Moderna, Inc.
$78.65BUSD
REGN
Regeneron Pharmaceuticals, Inc.
$76.14BUSDP/E 18.3
ARGX
argenx SE
$51.48BUSDP/E 31.2
ARGX
argenx SE
$48.23BUSDP/E 31.4
UCB
UCB SA
$41.82BUSDP/E 17.8
RVMD
Revolution Medicines, Inc.
$40.32BUSD
ONC
BeOne Medicines AG
$39.83BUSDP/E 62.6
RPRX
Royalty Pharma plc
$32.48BUSDP/E 29.9
ALNY
Alnylam Pharmaceuticals, Inc.
$30.04BUSDP/E 37.9
ROIV
Roivant Sciences Ltd.
$24.71BUSD
BNTX
BioNTech SE
$23.13BUSD
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
GMAB
Genmab A/S
$22.17BUSDP/E 28.4
INSM
Insmed Incorporated
$21.94BUSD
GMAB
Genmab A/S
$21.10BUSDP/E 29.1
ASND
Ascendis Pharma A/S
$14.65BUSDP/E 17.1
EXEL
Exelixis, Inc.
$14.62BUSDP/E 18.6
JAZZ
Jazz Pharmaceuticals plc
$14.44BUSDP/E 15.2
SMMT
Summit Therapeutics Inc.
$13.70BUSD

Key Statistics

Company
Market Cap35.11M USD
Enterprise Value41.51M USD
Revenue (TTM)35.00K USD
Gross Profit-392.00K USD
Net Income (TTM)-11.84M USD
Revenue/Share0.0060 USD
Last Price4.110 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees2
CountryUS
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)0.37
P/E (Forward)—
PEG—
EV/EBITDA-10.50
EV/Revenue1186.06
P/S1003.27
P/B3.26
EPS (TTM)11.11
EPS (Forward)—
52W Range
4.1000% of range10.51
52W High10.51 USD
52W Low4.100 USD
Profitability
Gross Margin-1225.00%
Oper. Margin-23400.00%
EBITDA Margin0.00%
Profit Margin-36993.75%
ROE-93.89%
ROA-68.01%
Growth
Revenue Growth-57.10%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.89M USD
CapEx (TTM)—
FCF Margin2905.36%
FCF Yield2.90%
Net Debt-10.00K USD
Net Debt/EBITDA0.00
Balance Sheet
Debt/Equity9.49
Current Ratio0.16
Quick Ratio0.01
Book Value/Sh1.26 USD
Cash/Share0.0010 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split79:1000
Split DateSep 23, 2026
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.8.54M
Float910.34K
Insiders89.02%
Institutions3.56%
Short Interest
Short Ratio2.0d
Short % Float4.49%
Short % Out.0.49%
Shares Short41.76K
Short (prev mo.)43.32K
Technical
SMA 505.829 (-29.5%)
SMA 2006.522 (-37.0%)
Beta2.73
S&P 52W Chg15.84%
Avg Vol (30d)21.34K
Avg Vol (10d)13.54K
Technical Indicators
RSI (14)29.7
MACD-0.3996
MACD Signal-0.1756
MACD Hist.-0.2240
BB Upper7.541 USD
BB Middle5.778 USD
BB Lower4.014 USD
BB Width61.06%
ATR (14)0.5657 USD
Vol Ratio (20d)1.28x